Drug intelligence / Profile preview

Cebion

Development stage
Unknown
Lead developer
Bracco
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Cebion is an over-the-counter vitamin C preparation whose active ingredient is ascorbic acid, a water-soluble vitamin essential for collagen synthesis, carnitine and catecholamine biosynthesis, and numerous redox reactions. It is used for the prevention and treatment of vitamin C deficiency and scurvy, and as an antioxidant support in conditions associated with increased oxidative stress, impaired wound and bone healing, or increased requirements, including infections and after surgery.[1][3][5][9][11][13] Ascorbic acid acts as a reducing agent and free-radical scavenger, supports immune function, enhances non‑heme iron absorption, and helps maintain connective tissue integrity by serving as a cofactor for prolyl and lysyl hydroxylases in collagen maturation.[3][9][11][13] Cebion is marketed in multiple oral dosage forms (drops, chewable and effervescent tablets) for adults and children and is a long‑standing vitamin C brand historically associated with companies such as Merck and Bracco in various markets.[4][6][10][12][14][15]

Brand names
Cebion
02

Targets

P4H (Prolyl 4-hydroxylase subunit alpha-3)DBH (Dopamine beta-hydroxylase)Carnitine biosynthesis enzymesSLC23A1 (Solute carrier family 23 member 1)SLC23A2 (Sodium-dependent vitamin C transporter 2)PAM (Peptidylglycine alpha-amidating monooxygenase)HPPD (4-Hydroxyphenylpyruvate dioxygenase)LH (Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1)

Beyond the preview

Go deeper on Cebion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cebion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call